Kongress
060-0001 Sapporo, Japan
125th Annual Meeting of the Japanese Ophthalmological Society
JOS Meeting 2022060-0001 Sapporo, Japan
Veranstaltungsnummer: 34622
Gebühren ab:
gebührenfrei
verfügbare Plätze:
unbegrenzt
Sprache:
Englisch, Japanisch
Zum Kalender hinzufügen
-
Datum
14.04.2022, 00:00 - 17.04.2022, 00:00Veranstalter
Japanese Ophthalmological Society (JOS)Kurzbeschreibung
The annual meeting of the Japanese Ophthalmology Society (JOS) is the Japanese forum for announcing the results of basic and clinical research. The 119th meeting will be held in Sapporo, Japan. An extended system of travel grants is implemented to encourage participation from overseas. The framework for English language sessions will be expanded, making it possible for English papers and presentations to be delivered at any time during the program.Gebühren
Fachärzte
Teilnehmer max.
unbegrenzt
Gebühren ab
kostenlosHinweis
k.A.Ärzte/-innen in Weiterbildung
Teilnehmer max.
unbegrenzt
Gebühren ab
kostenlosHinweis
k.A.medizinisches Fachpersonal
Teilnehmer max.
unbegrenzt
Gebühren ab
kostenlosHinweis
k.A.Orthoptisten/-innen
Teilnehmer max.
unbegrenzt
Gebühren ab
kostenlosHinweis
k.A.Studenten/-innen
Teilnehmer max.
unbegrenzt
Gebühren ab
kostenlosHinweis
k.A. -
Special lecture Special Lecture 1 Data science in the retina Special Lecture 2 Elucidation of the pathophysiology of retinal vitreous disease-starting from simple clinical questions Invited lecture Invited Talk 1 Clinical trials for glaucoma treatments: lessons from the UK Glaucoma Treatment Study Invited Talk 2 Management of fluid in AMD Board of Trustees Nomination Lecture Minimizing invasiveness of ophthalmic examinations and treatments Growth and maturity of OCT Angiography Minimizing invasiveness of corneal biopsy and corneal transplant surgery Challenge to reduce invasiveness in diagnosis and treatment of diabetic retinopathy Symposium Symposium 1 Forefront of Ocular Surface Immunology Research Mechanism of aggravation of eye allergy and new treatments Immunological Mechanisms of GVHD and New Therapies Possibility of immune tole-rance in corneal trans-plantation using regulatory T cells Elucidation of molecular profiles involved in regulatory T cell plasticity and heterogeneity in corneal transplantation using multiomics machine learning Inflammatory changes in the anterior chamber environment associated with the loss of corneal endothelial cells Symposium 2 Development of new treatments for keratoconjunctival diseases Drug treatment for Fuchs corneal endothelial dystrophy Corneal regenerative medicine using iPS cells Gene therapy for hereditary corneal disease Gene therapy for corneal disease Symposium 3 Challenge to transparent and regenerated crystalline lens Protein aggregation and its suppression by molecular chaperones Prevention of cataracts by the antioxidant action of flavonoidsPossibility of lens regeneration using cells Possibility of lens transparency with lanosterol Possibility of maintaining transparency by controlling oxidative stress of the crystalline lens Symposium 4 Science of future glaucoma treatment-Glaucoma eye drops first? Light and dark of eye drop treatment Possibility of microhook trabecrotomy as an alternative treatment for drugs Aiming for drug-free Ex-press surgery MIGS adaptation criteria in the real world Laser treatment as a first choice Symposium 5 New trends in glaucoma testing Corneal biomechanics and glaucoma Innovation in tonometry How to use polarized light-sensitive OCT Blood flow in and around the optic disc in glaucoma Diagnosis of secondary glaucoma of uveitis using comprehensive PCR test Symposium 6 Macular disease treatment strategy considering visual function Macular disease and color vision Branch retinal vein occlusion and contrast sensitivity Metamorphopsia after retinal detachment surgery Treatment of cases of macular disease with glaucoma Factors of metamorphopsia in the epiretinal membrane Symposium 7 Consider the target disease of retinal regenerative medicine Current status of photoreceptor cell transplantation Indications for retinal pigment epithelial transplantation About surgical techniques for regenerative medicine Current status of gene therapy Symposium 8 New evaluation methods and biomarkers for intraocular inflammatory diseases Diagnostic value of anterior ocular OCT in ocular inflammatory diseases Evaluation of vitreous infiltrating cells using OCT Diagnosis and evaluation of ocular inflammatory diseases using OCT-angiography and wide-angle OCTEstablishment of new biomarkers using biological samples in ocular inflammatory diseases Symposium 9 Translational research aimed at overcoming intractable optic nerve disease Maintenance therapy for anti-AQP4 antibody-positive optic neuritis and new promising therapeutic agents Bench to bedside in anti-MOG antibody-positive optic neuritis Elucidation of the pathophysiology of Leber's hereditary optic neuropathy using iPS cells Disease cell model and potential treatment for optic nerve disease Symposium 10 Squint surgery aimed at improving QOV Pediatric strabismus surgery aimed at improving QOV Rectus femoris partial incision New eye muscle movement Intraoperative adjustment method for strabismus Symposium 11 Management of myopia in adulthood Refraction correction management for myopia in young people (mainly CL) Refractive surgery for myopia in young people Cataract surgery in myopic eyes Fundus management in myopia of middle-aged and elderly people Glaucoma management in middle-aged and older people with myopia Symposium 12 The role of molecular pathology in the diagnosis and prognosis of eye tumors Molecular pathology and radiation therapy for conjunctival malignant lymphoma Utilization of artificial intelligence in pathological diagnosis of ocular tumor area Biomarkers in the diagnosis and prognosis of intraocular lymphoma Relationship between molecular pathology and clinical course of choroidal malignant melanoma Genetic testing in retinoblastoma Symposium 13 Biometry of main effects and side effects of various drugs Effects of various ophthalmic treatments on tear fluid (changes in mybography and interferometry findings) Biometry of main effects and side effects of anti-glaucoma eye drops-effects on the cornea Biometry of main effects and side effects of anti-glaucoma eye drops-effects on the posterior segment of the eye Main effects and side effects of anti-VEGF drugs Imaging-Clinical evaluation including side effects Eye disorders caused by antitumor drugs-various molecular-targeted drugs, microtubule depolymerization inhibitors, etc. Symposium 14 Current status and issues of smart sites Background and progress of development of Hyogo prefecture version smart site "Tsubasa" Low Vision Care for Car Society Current Status and Issues of Tochigi Prefecture Smart Site Creation and operation of Tokyo low vision care network Nationwide expansion and issues of smart sites by the Japan Ophthalmologists Association Aiming for the evolution of smart site models Symposium 15 Basic Research Seminar "New Developments in Basic Research in the Post-Genome Era" Environmentally responsive epigenome control and phenotypic variations Oxygen and Sulfur Biomimetics-Reactive Oxygen It was Reactive Sulfur! Expansion of physiological functions through autophagy and its selectivity Symposium 16 Science Pachychoroid New insights on the pathophysiology of pachychoroid from imaging studies Clinical pathology of Pachychoroid Pachychoroid and cytokine dynamics Diagnosis of Pachychoroid Treatment of Pachychoroid Symposium 17 Anti-VEGF treatment for age-related macular degeneration-Treatment strategy based on pathophysiology and efficacy Characteristics and uses of anti-VEGF drugs including new drugs Correlation between neovascular morphology and activity using OCTA Treatment strategies for typical AMD Treatment Strategy for PCV Treatment strategy for RAP Post-treatment RPE atrophy trends and responses Symposium 18 Strategic Planning Council Fourth Committee Frame Symposium 19 Current status and future of ophthalmic AI / big data How can we trust AI Retina AI Corneal AI Tumor AICataract surgery AI Glaucoma AI Symposium 20 Changes in ophthalmic medical expenses in Japan Changes in medical expenses in Japan Cataract medical expenses and the plight of ophthalmologists have been shrinking for the past 21 years Changes in ophthalmic medical expenses over the past 21 years using national medical expenses Changes in medical expenses at hospitals International Symposium International Symposium 1 Advances in keratoplasty and eye banking Optimized outcome in high-risk "keratoplasty: crosslink, FND & more" Surgical approach to successful Deep Anterior Lamellar Keratoplasty (DALK) Post-keratoplasty fungal infections: prevention and management Endothelium-In DMEK for Standard and Complex Cases What I learned from my DMEK Surgery New Graft Insertion Device fro DSAEK International Symposium 2 Glaucoma laser treatment: Evolving techniques and novel evidences Overview of laser treatment against glaucoma Current management of PACS: Lessons from the ZAP and ANA-LIS trials Trend and Cost-effectiveness for Treatment of glaucoma in Korea: Medication, Laser treatment, Surgery Selective Laser Trabeculoplasty - Findings from the LiGHT Study International Symposium 3 Research advancement in the pathology of age-related macular degeneration Pachychoroid neovasculopathy and exudative changes Profiling of lipoprotein subclasses and fatty acids in age-related macular degeneration Pathogens of age-related macular degeneration The relationship between choroidal flow deficits and 3D complexity of neovascularization in AMD International Symposium 4 Cutting edge of vitreoretinal surgery AI Application in ROP TBD Treatment of endophthalmitis using povidone iodine The effect of cystotomy for treatment refractory diabetic macular edema International Symposium 5 For standardized protocol of Japanese School Myopia TBD For standardized protocol of Japanese School Myopia Low-concentration atropine for myopia control Outdoor activities and myopia prevention: Taiwan's experience Community and School-Based Intervention in Children Myopia Control Educational Seminar Educational Seminar 1 Higher-order aberrations and eye diseases Basics of higher order aberrations Dry eye / corneal disease and higher order aberrations Age-related changes in the crystalline lens, cataracts and higher-order aberrations Refraction (myopia) and higher order aberrations Refractive surgery and higher order aberrations Educational Seminar 2 View of OCT findings that should be known clinically OCT in glaucoma treatment OCT in RVO practice OCT in AMD practice OCT in neuro-ophthalmology OCT in high-intensity myopic eye care Educational Seminar 3 Diagnosis and treatment of human herpesvirus eye infections Diagnosis and treatment of corneal herpes Shingles of the eye Acute retinal necrosis Cytomegalovirus uveitis / iritis Cytomegalovirus retinitis Uveitis due to EB virus and HHV6 Educational Seminar 4 Discovery and coping with white pupil / pupil territory cloudiness Current status of visual screening Congenital / developmental cataract Fundus disease Retinoblastoma Educational Seminar 5 Theory and practice of presbyopia correction by CL Theory of presbyopia correction - Correction for eyestrain Correction for astigmatic eyesIntraocular lens correction for the eye Correction for women Educational Seminar 6 Correlation between clinical and pathological findings of the eye Correlation between clinical and pathological findings of conjunctival disease Correlation between clinical and pathological findings of eyelid disease Relationship between vitreous cytology and fundus disease Correlation between clinical and pathological findings of retinal disease Correlation between clinical and pathological findings of uveal disease Educational Seminar 7 100 years of life: healthy life expectancy and the role of ophthalmic medicine Introduction: Aging and eyes, healthy life expectancy Aiming to extend healthy life expectancy-Actual and effective verification of specific examinations and health guidance Flail and healthy life expectancy Eye flail and healthy life expectancy Educational Seminar 8 Concept and treatment method of recent ophthalmic surgery indication Concept and treatment of surgical indications for corneal diseases Concept of cataract surgery indication Recent glaucoma surgery indications and ideas Reasonable adaptation of retinal vitreous surgery Surgery indications for ptosis - Disputes regarding surgical procedures and medical cooperation -
Royton Sapporo
Japanese Ophthalmological Society (JOS)
2-4-11-402 Sarugakucho
JP - 101-8346 Tokyo
Tel.: +81 3 3295 2360
Fax: +81 3 3293 9384 -
Please click here for online registration.